|
Olympus reviewed the following literature titled "validation of a novel bcm model for recurrence risk prediction after mucosectomy of colorectal lateral spreading tumors in a european cohort".Literature summary: background and aim: piecemeal endoscopic mucosal resection (pemr) is the best approach to resect large lateral spreading tumors (lst, > 20 mm width).However, it is associated with early recurrence (er) and late recurrence (lr).This study aims to assess the risk factors associated with er and lr and to validate different predictive scores (smsa, sert, and bcm) in identifying the risk of er and lr after lst resected by pemr in a european cohort.Methods: retrospective observational cohort study, based on a prospectively collected database, of large lst submitted to pemr.Results: a total of 108 patients were included in the study and the incidence rates of er and lr were 22 % and 8%, respectively.The lesion¿s size, sert, and bcm scores were independent predictor factors of er (p-value <0.05), while the lesion¿s site and bcm score were independent predictor factors of lr (p-value < 0.05).For the prediction of er, the sert score (cut-off > 1) presented the highest auroc (0.758 vs 0.697 from bcm and 0.647 from smsa).Regarding lr, the bcm model (cut-off > 2) presented the highest auroc (0.817 vs 0.708 from sert and 0.691 from smsa).Conclusions: we present the first external validation of the three scores mentioned in an european cohort.Sert and bcm scores had an acceptable performance in predicting er and lr.However, the bcm model was the only score that proved to be an independent predictor of both er and lr, proving to be valuable for both applications.¿type of adverse events/number of patients¿ intraprocedural bleeding (30) delayed bleeding (4) colorectal perforation (2) post-polypectomy syndrome (3) intraprocedural bleeding (30 patients) and delayed bleeding (4 patients) were all treated endoscopically.Colorectal perforation occurred in 2 patients.One was treated surgically, and one was treated endoscopically.Post-polypectomy syndrome (3 patients) was treated with antibiotics.
|
|
This report is related to the following linked patient identifiers: (b)(6).The device was not returned.Attempts were performed to obtain additional information, but no response was received.Should additional relevant information become available, a supplemental report will be submitted.
|
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the reported event was likely an accident, or a complication associated with a surgical procedure while using the subject device.There was no complaint reported on the subject device and no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
|